Expression of Toll-like receptor 2 is up-regulated in monocytes from patients with chronic obstructive pulmonary disease
2006

Toll-like receptor 2 and chronic obstructive pulmonary disease

Sample size: 75 publication Evidence: moderate

Author Information

Author(s): Pons Jaume, Sauleda Jaume, Regueiro Verónica, Santos Carmen, López Meritxell, Ferrer Joana, Agustí Alvar GN, Bengoechea José A

Primary Institution: Unidad de Investigación, Hospital Son Dureta, Institut Universitari d'Investigacions en Ciències de la Salut (IUNICS), Palma Mallorca, Spain

Hypothesis

We hypothesized that TLR may participate in the regulation of inflammation in COPD, particularly during the episodes of AECOPD.

Conclusion

The study reveals abnormalities in TLRs expression in COPD patients and highlights its potential relationship with systemic inflammation.

Supporting Evidence

  • TLR-2 expression was up-regulated in monocytes from COPD patients compared to never smokers.
  • Monocytes from COPD patients secreted more cytokines upon stimulation than those from never smokers.
  • At discharge, TLR-2 expression was down-regulated in AECOPD patients.
  • IL-6 up-regulated TLR-2 expression in vitro in monocytes from never smokers.

Takeaway

This study found that a specific receptor, TLR-2, is more active in patients with a lung disease called COPD, which might be linked to inflammation in their bodies.

Methodology

The expression of TLR-2, TLR-4, and CD14 in monocytes was analyzed by flow cytometry, and functional responses were studied by stimulating monocytes with specific ligands.

Potential Biases

Potential bias due to the exclusion of patients with atopic diseases and the small sample size for some analyses.

Limitations

The study only analyzed circulating monocytes and not alveolar macrophages, and the small blood volume limited the number of analyses per patient.

Participant Demographics

Participants included never smokers, smokers with normal lung function, stable COPD patients, and AECOPD patients, with a mean age range of 57.8 to 65.0 years.

Statistical Information

P-Value

0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1465-9921-7-64

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication